2025
article
OpenAlex
Junichirô Itani, Takeshi Ishikawa, Toshifumi Doi, Daiki Sone et autres
Abstract Background In Japan, combination chemotherapy with 5-FU + CDDP (FP) and immune checkpoint inhibitors (ICIs) and dual ICI combination therapy have been approved for use in first-line treatment of recurrent/unresectable esophageal cancer since November 2021, and have become widely used in …
jp
(code pays fourni par la source)
Accès ouvert
2025
erratum
OpenAlex
Yuya Suzuki, Takuo Emoto, Shunsuke Sato, Takeshi Yoshida et autres
In the version of the article initially published, in the “Myeloid cells signal FBs via the EGF and platelet-derived growth factor (PDGF) pathways” section, the sentence “GO enrichment analysis revealed enrichment of ‘response to fibroblast growth factor’ and ‘myeloid leukocyte differentiation’ (biological …
jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Yuya Suzuki, Takuo Emoto, Shunsuke Sato, Takeshi Yoshida et autres
Atrial fibrillation (AF) is strongly associated with strokes, heart failure, and increased mortality. This study aims to identify the monocyte–macrophage heterogeneity and interactions of these cells with non-immune cells, and to identify functional biomarkers in patients with AF. Therefore, we assess the …
jp
(code pays fourni par la source)
2024
article
OpenAlex
Helge Immo Lehmann, Hiroki Konishi, Songyun Wang, Stephan W. Hohmann et autres
us, cn
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Shuhei Hige, Kouji Aoki, Daisuke Nakamoto, John F. Flaherty et autres
Tenofovir alafenamide (TAF), a prodrug of tenofovir, delivers high levels of active drug to hepatocytes and is given in a lower dose than tenofovir disoproxil fumarate (TDF). TAF reduces viral replication in patients with chronic hepatitis B (CHB) similar to TDF and …
jp, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Sato Namura, Hiroki Konishi, Ryo Nishio, Hiroshi Yamamoto
Background: Coronary-to-pulmonary artery fistula (CPF) is a rare disease, and its optimal treatment strategy remains controversial. Herein, we report a rare case of minimally invasive coil embolization of giant CPFs. Case summary: A 78-year-old man with a history of persistent atrial fibrillation …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Wako Suehiro, Ryo Nishio, Jun‐ichi Noiri, Ryo Takeshige et autres
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Kimitake Imamura, A. Deisher, Jannis Dickow, Maryam E. Rettmann et autres
Background: Particle therapy is a noninvasive, catheter-free modality for cardiac ablation. We previously demonstrated the efficacy for creating ablation lesions in the porcine heart. Despite several earlier studies, the exact mechanism of early biophysical effects of proton and photon beam delivery on …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Tatsuhiko Hirao, Kimitake Imamura, Atsushi Suzuki, Stephan W. Hohmann et autres
2023
conference-paper
OpenAlex
Maryam E. Rettmann, A. Deisher, Tatsuhiko Hirao, Naoto Otsuka et autres
Cardiac motion remains a challenge in the treatment of ventricular tachycardia with external beam ablation therapy. Current techniques involve expansion of the treatment area which can lead to unwanted collateral damage. Surrounding healthy tissue could be spared by gating the delivery of …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jun‐ichi Noiri, Hiroki Konishi, Hiroki Matsuzoe
Limited studies report on the status of surgical closure patches for atrial septal defect (ASD) in the remote period. In our case, transthoracic echocardiography revealed a fistula of ASD patch before pulmonary vein isolation for atrial fibrillation. Preoperative Imaging examinations aid in …
jp
(code pays fourni par la source)
2022
conference-abstract
OpenAlex
Tatsuhiko Hirao, Kimitake Imamura, Atsushi Suzuki, Maryam E. Rettmann et autres
Background: Cardiac proton beam ablation therapy has emerged as a promising tool for catheter-free arrhythmia ablation. The time course of the lesion change was demonstrated in MRI 8 weeks following the ablation; however, the pericardial effusion after the ablation has not been …
us
(code pays fourni par la source)